drugset / Trial / NCT02102139

Preop Dexmedetomidine Attenuates Haemodynamic Responses to Hydrodissection

NCT02102139 ↗

Phase 4 Completed 41 enrolled Seoul National University Hospital
RandomizedSingle-groupTriple-blindSupportive care

Summary

Percutaneous tunnelling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant haemodynamic responses such as increases in blood pressure and heart rate. The investigators evaluated whether a single preoperative dexmedetomidine injection attenuated the haemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain haemodynamic stability during hydrodissection.

Timeline

Start
2012-05
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Background Propofol Small molecule — —

Indications

No indication recorded.